Repligen saw the highest growth of 1.32% in patent filings in May and 0.74% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.74% and grants by 0.74%. GlobalData’s DataBook provides a comprehensive analysis of Repligen‘s patent filings and grants. Buy the databook here.
Repligen has been focused on protecting inventions in United States(US) with six publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 44% filings and 50% grants. The World Intellectual Property Organization(WIPO), United States(US), China(CN), and South Korea(KR) patent Office are among the top ten patent offices where Repligen is filings its patents. Among the top granted patent authorities, Repligen has 50% of its grants in United States(US), 25% in China(CN) and 25% in South Korea(KR).
E. Merck and Sartorius could be the strongest competitors for Repligen
Patents related to industrial automation lead Repligen's portfolio
Repligen has the highest number of patents in industrial automation. For industrial automation, nearly 100% of patents were filed and no patents were granted in Q2 2024.
Television related patents lead Repligen portfolio followed by assembly & testing
Repligen has highest number of patents in television followed by assembly & testing.
For comprehensive analysis of Repligen's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.